Abayon, Romeo L.
HRN: 22-11-33 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/19/2024
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
08/19/2024
08/26/2024
IV
500mg
Q8H
Indirect Inguinal Hernia, R
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominalReproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes